ReviewExperimental parasitology2007
Molecular methods for diagnosis of Entamoeba histolytica in a clinical setting: an overview.
Review in Experimental parasitology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Review
- Amoebic Liver Abscess: Potential Application of New Diagnostic Techniques for an Old Pathogen.Infectious diseases and therapy · 2024Article
- Molecular Detection of a PathogenicPolish journal of microbiology · 2024Article
- Creep in nitroimidazole inhibitory concentration among the Entamoeba histolytica isolates causing amoebic liver abscess and screening of andrographolide as a repurposing drug.Scientific reports · 2023Article
- Molecular-Genotyping Detection ofArchives of Razi Institute · 2023Article
- Fluorescent non transgenic schistosoma to decipher host-parasite phenotype compatibility.Frontiers in immunology · 2023Article
- Molecular Identification and Prevalence ofPolish journal of microbiology · 2020Article
- Amoebic liver abscess in northern Sri Lanka: first report of immunological and molecular confirmation of aetiology.Parasites & vectors · 2017Article
- Proteome analysis of excretory-secretory proteins ofClinical proteomics · 2016Article
- Enhancing Protein Capture Using a Combination of Nanoyeast Single-Chain Fragment Affinity Reagents and Alternating Current Electrohydrodynamic Forces.Analytical chemistry · 2015Article
- Different clinical outcomes of Entamoeba histolytica in Malaysia: does genetic diversity exist?The Korean journal of parasitology · 2013Article
- Analysis of Entamoeba histolytica excretory-secretory antigen and identification of a new potential diagnostic marker.Clinical and vaccine immunology : CVI · 2011Article
- Hepatic amebiasis: a reminder of the complications.Current opinion in pediatrics · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The range of clinical outcomes following Entamoeba histolytica infection is likely to be influenced by the different strains of the parasite already existing in our population. There is a need for developing faster, reliable and reproducible methods for identifying the different strains of E. histolytica. This would have a major impact on the subsequent course of treatment given to patients. In the post-genomic era, different loci of the Entamoeba genome have been targeted for developing suitable probes and genetic markers. This review highlights the development made in this direction and the possibility of using these methods for routine testing of this parasite in clinical samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.